HEADER HYDROLASE/HYDROLASE INHIBITOR 27-SEP-95 1BIL TITLE CRYSTALLOGRAPHIC STUDIES ON THE BINDING MODES OF P2-P3 BUTANEDIAMIDE TITLE 2 RENIN INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: RENIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ANGIOTENSINOGENASE; COMPND 5 EC: 3.4.23.15; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: GLYCOSYLATED SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CMV IE-HUMAN PREPRORENIN CDNA, REN; SOURCE 6 EXPRESSION_SYSTEM: STABLY TRANSFERRED DOG EPITHELIAL CELL; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PMNC RETROVIRAL VECTOR; SOURCE 8 EXPRESSION_SYSTEM_GENE: CMV IE-HUMAN PREPRORENIN CDNA KEYWDS ASPARTIC PROTEINASE, ASPARTYL PROTEASE, CLEAVAGE ON PAIR OF BASIC KEYWDS 2 RESIDUES, DISEASE MUTATION, DISULFIDE BOND, GLYCOPROTEIN, HYDROLASE, KEYWDS 3 MEMBRANE, PROTEASE, SECRETED, ZYMOGEN, HYDROLASE-HYDROLASE INHIBITOR KEYWDS 4 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR L.TONG REVDAT 8 16-OCT-24 1BIL 1 REMARK REVDAT 7 09-MAR-22 1BIL 1 COMPND REMARK HETNAM REVDAT 6 14-AUG-19 1BIL 1 REMARK REVDAT 5 17-JUL-19 1BIL 1 REMARK REVDAT 4 18-JAN-12 1BIL 1 REMARK REVDAT 3 13-JUL-11 1BIL 1 VERSN REVDAT 2 24-FEB-09 1BIL 1 VERSN REVDAT 1 29-JAN-96 1BIL 0 JRNL AUTH L.TONG,S.PAV,D.LAMARRE,B.SIMONEAU,P.LAVALLEE,G.JUNG JRNL TITL CRYSTALLOGRAPHIC STUDIES ON THE BINDING MODES OF P2-P3 JRNL TITL 2 BUTANEDIAMIDE RENIN INHIBITORS. JRNL REF J.BIOL.CHEM. V. 270 29520 1995 JRNL REFN ISSN 0021-9258 JRNL PMID 7493993 JRNL DOI 10.1074/JBC.270.49.29520 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 6.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 32160 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.170 REMARK 3 R VALUE (WORKING SET) : 0.170 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5125 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 90 REMARK 3 SOLVENT ATOMS : 135 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : NULL ; NULL ; NULL REMARK 3 BOND ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES (A) : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS (A) : NULL ; NULL ; NULL REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : NULL REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1BIL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000171800. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.77 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 5555 Z,X,Y REMARK 290 6555 Z+1/2,-X+1/2,-Y REMARK 290 7555 -Z+1/2,-X,Y+1/2 REMARK 290 8555 -Z,X+1/2,-Y+1/2 REMARK 290 9555 Y,Z,X REMARK 290 10555 -Y,Z+1/2,-X+1/2 REMARK 290 11555 Y+1/2,-Z+1/2,-X REMARK 290 12555 -Y+1/2,-Z,X+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 71.55000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 71.55000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 71.55000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 71.55000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 71.55000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 71.55000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY2 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY1 6 0.000000 0.000000 1.000000 71.55000 REMARK 290 SMTRY2 6 -1.000000 0.000000 0.000000 71.55000 REMARK 290 SMTRY3 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 0.000000 -1.000000 71.55000 REMARK 290 SMTRY2 7 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 1.000000 0.000000 71.55000 REMARK 290 SMTRY1 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY2 8 1.000000 0.000000 0.000000 71.55000 REMARK 290 SMTRY3 8 0.000000 -1.000000 0.000000 71.55000 REMARK 290 SMTRY1 9 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 9 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY3 9 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY1 10 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 10 0.000000 0.000000 1.000000 71.55000 REMARK 290 SMTRY3 10 -1.000000 0.000000 0.000000 71.55000 REMARK 290 SMTRY1 11 0.000000 1.000000 0.000000 71.55000 REMARK 290 SMTRY2 11 0.000000 0.000000 -1.000000 71.55000 REMARK 290 SMTRY3 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY1 12 0.000000 -1.000000 0.000000 71.55000 REMARK 290 SMTRY2 12 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY3 12 1.000000 0.000000 0.000000 71.55000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 160A REMARK 465 SER A 160B REMARK 465 GLN A 160C REMARK 465 GLU B 159A REMARK 465 ASN B 159B REMARK 465 SER B 159C REMARK 465 GLN B 159D REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG B 74 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 132 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 238 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 17 CD GLU A 17 OE2 0.070 REMARK 500 GLU A 70 CD GLU A 70 OE1 0.094 REMARK 500 GLU A 148 CD GLU A 148 OE2 0.075 REMARK 500 GLU A 160 CD GLU A 160 OE1 0.087 REMARK 500 GLU A 207 CD GLU A 207 OE1 0.080 REMARK 500 GLU A 229 CD GLU A 229 OE2 0.103 REMARK 500 GLU A 233 CD GLU A 233 OE2 0.086 REMARK 500 GLU A 251 CD GLU A 251 OE1 0.090 REMARK 500 GLU A 266 CD GLU A 266 OE2 0.102 REMARK 500 GLU A 278 CD GLU A 278 OE2 0.094 REMARK 500 GLU B 17 CD GLU B 17 OE2 0.089 REMARK 500 GLU B 70 CD GLU B 70 OE2 0.075 REMARK 500 GLU B 103 CD GLU B 103 OE2 0.070 REMARK 500 GLU B 106 CD GLU B 106 OE2 0.087 REMARK 500 GLU B 148 CD GLU B 148 OE1 0.083 REMARK 500 GLU B 176 CD GLU B 176 OE2 0.089 REMARK 500 GLU B 229 CD GLU B 229 OE1 0.096 REMARK 500 GLU B 233 CD GLU B 233 OE1 0.112 REMARK 500 GLU B 278 CD GLU B 278 OE2 0.124 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 57 CB - CG - OD2 ANGL. DEV. = 6.5 DEGREES REMARK 500 ARG A 74 NE - CZ - NH1 ANGL. DEV. = 4.8 DEGREES REMARK 500 ASP A 118 CB - CG - OD1 ANGL. DEV. = 6.4 DEGREES REMARK 500 ASP A 118 CB - CG - OD2 ANGL. DEV. = -5.6 DEGREES REMARK 500 ASP A 149 CB - CG - OD1 ANGL. DEV. = -5.9 DEGREES REMARK 500 ASP A 158 CB - CG - OD1 ANGL. DEV. = 6.5 DEGREES REMARK 500 ASP A 158 CB - CG - OD2 ANGL. DEV. = -8.8 DEGREES REMARK 500 ASP A 171 CB - CG - OD1 ANGL. DEV. = 5.5 DEGREES REMARK 500 ASP A 208 CB - CG - OD1 ANGL. DEV. = 7.4 DEGREES REMARK 500 TYR A 220 CB - CG - CD2 ANGL. DEV. = -4.0 DEGREES REMARK 500 ASP A 257 CB - CG - OD1 ANGL. DEV. = 6.3 DEGREES REMARK 500 ASP A 257 CB - CG - OD2 ANGL. DEV. = -5.8 DEGREES REMARK 500 ARG A 319 NE - CZ - NH1 ANGL. DEV. = 6.4 DEGREES REMARK 500 ARG A 319 NE - CZ - NH2 ANGL. DEV. = -6.2 DEGREES REMARK 500 ASP B 11 CB - CG - OD1 ANGL. DEV. = 7.6 DEGREES REMARK 500 ASP B 11 CB - CG - OD2 ANGL. DEV. = -5.8 DEGREES REMARK 500 ASP B 32 CB - CG - OD2 ANGL. DEV. = -5.9 DEGREES REMARK 500 ARG B 46A NE - CZ - NH2 ANGL. DEV. = -3.6 DEGREES REMARK 500 ASP B 60 CB - CG - OD2 ANGL. DEV. = -6.8 DEGREES REMARK 500 ASP B 87 CB - CG - OD1 ANGL. DEV. = 6.1 DEGREES REMARK 500 ASP B 87 CB - CG - OD2 ANGL. DEV. = -5.5 DEGREES REMARK 500 ASP B 118 CB - CG - OD2 ANGL. DEV. = -5.5 DEGREES REMARK 500 LYS B 147 N - CA - CB ANGL. DEV. = 12.7 DEGREES REMARK 500 ASP B 149 CB - CG - OD2 ANGL. DEV. = -8.6 DEGREES REMARK 500 HIS B 174 CA - CB - CG ANGL. DEV. = -10.3 DEGREES REMARK 500 ASP B 208 CB - CG - OD1 ANGL. DEV. = -7.3 DEGREES REMARK 500 ARG B 240 NE - CZ - NH2 ANGL. DEV. = -4.2 DEGREES REMARK 500 ASP B 244 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 TYR B 245 CB - CG - CD2 ANGL. DEV. = -3.9 DEGREES REMARK 500 ASP B 257 CB - CG - OD1 ANGL. DEV. = 7.0 DEGREES REMARK 500 ASP B 257 CB - CG - OD2 ANGL. DEV. = -6.1 DEGREES REMARK 500 TYR B 279A CB - CG - CD1 ANGL. DEV. = -4.1 DEGREES REMARK 500 MET B 289 CG - SD - CE ANGL. DEV. = -10.3 DEGREES REMARK 500 ASP B 290 CB - CG - OD1 ANGL. DEV. = 6.7 DEGREES REMARK 500 ASP B 290 CB - CG - OD2 ANGL. DEV. = -6.1 DEGREES REMARK 500 ARG B 307 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 ASP B 314 CB - CG - OD2 ANGL. DEV. = -6.2 DEGREES REMARK 500 ARG B 319 NE - CZ - NH1 ANGL. DEV. = 5.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 67 -66.72 -132.39 REMARK 500 ASP A 158 -150.65 -78.56 REMARK 500 THR A 203 72.30 -64.60 REMARK 500 ASP A 208 -44.80 76.69 REMARK 500 LEU A 242 -70.00 -47.08 REMARK 500 PRO A 253 5.52 -65.17 REMARK 500 SER A 279 165.59 174.00 REMARK 500 ALA A 285 49.42 -88.97 REMARK 500 ASN B 67 -63.77 -158.68 REMARK 500 ASP B 87 -175.36 -172.89 REMARK 500 ARG B 132 43.99 36.25 REMARK 500 VAL B 145 -73.99 59.65 REMARK 500 PRO B 172 2.46 -69.92 REMARK 500 ASP B 208 61.04 -108.51 REMARK 500 CYS B 210 -177.53 -173.58 REMARK 500 LEU B 242 -100.26 42.96 REMARK 500 PRO B 253 -7.87 -59.81 REMARK 500 ALA B 285 50.63 -94.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 HET GROUPS DMF, PHC, HII, CHA AND IP3 FORM AN INHIBITOR AND REMARK 600 REFERRED TO AS INHIBITOR NUMBER 1 IN THE MANUSCRIPT. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0IU A 391 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0IU B 391 DBREF 1BIL A -2 326 UNP P00797 RENI_HUMAN 70 406 DBREF 1BIL B -2 326 UNP P00797 RENI_HUMAN 70 406 SEQRES 1 A 337 GLY ASN THR THR SER SER VAL ILE LEU THR ASN TYR MET SEQRES 2 A 337 ASP THR GLN TYR TYR GLY GLU ILE GLY ILE GLY THR PRO SEQRES 3 A 337 PRO GLN THR PHE LYS VAL VAL PHE ASP THR GLY SER SER SEQRES 4 A 337 ASN VAL TRP VAL PRO SER SER LYS CYS SER ARG LEU TYR SEQRES 5 A 337 THR ALA CYS VAL TYR HIS LYS LEU PHE ASP ALA SER ASP SEQRES 6 A 337 SER SER SER TYR LYS HIS ASN GLY THR GLU LEU THR LEU SEQRES 7 A 337 ARG TYR SER THR GLY THR VAL SER GLY PHE LEU SER GLN SEQRES 8 A 337 ASP ILE ILE THR VAL GLY GLY ILE THR VAL THR GLN MET SEQRES 9 A 337 PHE GLY GLU VAL THR GLU MET PRO ALA LEU PRO PHE MET SEQRES 10 A 337 LEU ALA GLU PHE ASP GLY VAL VAL GLY MET GLY PHE ILE SEQRES 11 A 337 GLU GLN ALA ILE GLY ARG VAL THR PRO ILE PHE ASP ASN SEQRES 12 A 337 ILE ILE SER GLN GLY VAL LEU LYS GLU ASP VAL PHE SER SEQRES 13 A 337 PHE TYR TYR ASN ARG ASP SER GLU ASN SER GLN SER LEU SEQRES 14 A 337 GLY GLY GLN ILE VAL LEU GLY GLY SER ASP PRO GLN HIS SEQRES 15 A 337 TYR GLU GLY ASN PHE HIS TYR ILE ASN LEU ILE LYS THR SEQRES 16 A 337 GLY VAL TRP GLN ILE GLN MET LYS GLY VAL SER VAL GLY SEQRES 17 A 337 SER SER THR LEU LEU CYS GLU ASP GLY CYS LEU ALA LEU SEQRES 18 A 337 VAL ASP THR GLY ALA SER TYR ILE SER GLY SER THR SER SEQRES 19 A 337 SER ILE GLU LYS LEU MET GLU ALA LEU GLY ALA LYS LYS SEQRES 20 A 337 ARG LEU PHE ASP TYR VAL VAL LYS CYS ASN GLU GLY PRO SEQRES 21 A 337 THR LEU PRO ASP ILE SER PHE HIS LEU GLY GLY LYS GLU SEQRES 22 A 337 TYR THR LEU THR SER ALA ASP TYR VAL PHE GLN GLU SER SEQRES 23 A 337 TYR SER SER LYS LYS LEU CYS THR LEU ALA ILE HIS ALA SEQRES 24 A 337 MET ASP ILE PRO PRO PRO THR GLY PRO THR TRP ALA LEU SEQRES 25 A 337 GLY ALA THR PHE ILE ARG LYS PHE TYR THR GLU PHE ASP SEQRES 26 A 337 ARG ARG ASN ASN ARG ILE GLY PHE ALA LEU ALA ARG SEQRES 1 B 337 GLY ASN THR THR SER SER VAL ILE LEU THR ASN TYR MET SEQRES 2 B 337 ASP THR GLN TYR TYR GLY GLU ILE GLY ILE GLY THR PRO SEQRES 3 B 337 PRO GLN THR PHE LYS VAL VAL PHE ASP THR GLY SER SER SEQRES 4 B 337 ASN VAL TRP VAL PRO SER SER LYS CYS SER ARG LEU TYR SEQRES 5 B 337 THR ALA CYS VAL TYR HIS LYS LEU PHE ASP ALA SER ASP SEQRES 6 B 337 SER SER SER TYR LYS HIS ASN GLY THR GLU LEU THR LEU SEQRES 7 B 337 ARG TYR SER THR GLY THR VAL SER GLY PHE LEU SER GLN SEQRES 8 B 337 ASP ILE ILE THR VAL GLY GLY ILE THR VAL THR GLN MET SEQRES 9 B 337 PHE GLY GLU VAL THR GLU MET PRO ALA LEU PRO PHE MET SEQRES 10 B 337 LEU ALA GLU PHE ASP GLY VAL VAL GLY MET GLY PHE ILE SEQRES 11 B 337 GLU GLN ALA ILE GLY ARG VAL THR PRO ILE PHE ASP ASN SEQRES 12 B 337 ILE ILE SER GLN GLY VAL LEU LYS GLU ASP VAL PHE SER SEQRES 13 B 337 PHE TYR TYR ASN ARG ASP SER GLU ASN SER GLN SER LEU SEQRES 14 B 337 GLY GLY GLN ILE VAL LEU GLY GLY SER ASP PRO GLN HIS SEQRES 15 B 337 TYR GLU GLY ASN PHE HIS TYR ILE ASN LEU ILE LYS THR SEQRES 16 B 337 GLY VAL TRP GLN ILE GLN MET LYS GLY VAL SER VAL GLY SEQRES 17 B 337 SER SER THR LEU LEU CYS GLU ASP GLY CYS LEU ALA LEU SEQRES 18 B 337 VAL ASP THR GLY ALA SER TYR ILE SER GLY SER THR SER SEQRES 19 B 337 SER ILE GLU LYS LEU MET GLU ALA LEU GLY ALA LYS LYS SEQRES 20 B 337 ARG LEU PHE ASP TYR VAL VAL LYS CYS ASN GLU GLY PRO SEQRES 21 B 337 THR LEU PRO ASP ILE SER PHE HIS LEU GLY GLY LYS GLU SEQRES 22 B 337 TYR THR LEU THR SER ALA ASP TYR VAL PHE GLN GLU SER SEQRES 23 B 337 TYR SER SER LYS LYS LEU CYS THR LEU ALA ILE HIS ALA SEQRES 24 B 337 MET ASP ILE PRO PRO PRO THR GLY PRO THR TRP ALA LEU SEQRES 25 B 337 GLY ALA THR PHE ILE ARG LYS PHE TYR THR GLU PHE ASP SEQRES 26 B 337 ARG ARG ASN ASN ARG ILE GLY PHE ALA LEU ALA ARG HET 0IU A 391 45 HET 0IU B 391 45 HETNAM 0IU (2S)-2-[(2-AMINO-1,3-THIAZOL-4-YL)METHYL]-N~1~-[(1S,2R, HETNAM 2 0IU 3R)-1-(CYCLOHEXYLMETHYL)-2,3-DIHYDROXY-5-METHYLHEXYL]- HETNAM 3 0IU N~4~-[2-(D IMETHYLAMINO)-2-OXOETHYL]-N~4~-[(1S)-1- HETNAM 4 0IU PHENYLETHYL]BUTANEDIAMIDE HETSYN 0IU P2-P3 BUTANEDIAMIDE RENIN INHIBITOR (1) FORMUL 3 0IU 2(C34 H53 N5 O5 S) FORMUL 5 HOH *135(H2 O) HELIX 1 1 THR A 48 CYS A 50 5 3 HELIX 2 2 ALA A 58 ASP A 60 5 3 HELIX 3 3 ALA A 109 LEU A 114 1 6 HELIX 4 4 ILE A 126 GLN A 128 5 3 HELIX 5 5 ILE A 130 ARG A 132 5 3 HELIX 6 6 ILE A 136 GLN A 143 1 8 HELIX 7 7 THR A 225 LEU A 235 1 11 HELIX 8 8 GLY A 252 THR A 254 5 3 HELIX 9 9 SER A 271 TYR A 274 1 4 HELIX 10 10 ALA A 303 ILE A 306 1 4 HELIX 11 11 THR B 48 TYR B 52 1 5 HELIX 12 12 ALA B 58 ASP B 60 5 3 HELIX 13 13 ALA B 109 LEU B 114 1 6 HELIX 14 14 ILE B 126 GLN B 128 5 3 HELIX 15 15 ILE B 136 GLN B 143 1 8 HELIX 16 16 THR B 225 LEU B 235 1 11 HELIX 17 17 CYS B 249 THR B 254 5 6 HELIX 18 18 SER B 271 TYR B 274 1 4 HELIX 19 19 ALA B 303 ILE B 306 1 4 SHEET 1 A 6 SER A 2 ILE A 5 0 SHEET 2 A 6 GLY A 163 LEU A 167 -1 N LEU A 167 O SER A 2 SHEET 3 A 6 VAL A 150 TYR A 155 -1 N TYR A 154 O GLN A 164 SHEET 4 A 6 PHE A 309 ASP A 314 -1 N PHE A 313 O PHE A 151 SHEET 5 A 6 ARG A 319 LEU A 324 -1 N ALA A 323 O TYR A 310 SHEET 6 A 6 HIS A 180 ASN A 183 -1 N ILE A 182 O ILE A 320 SHEET 1 B 4 THR A 7 TYR A 9 0 SHEET 2 B 4 GLN A 13 ILE A 20 -1 N TYR A 15 O THR A 7 SHEET 3 B 4 GLN A 25 ASP A 32 -1 N VAL A 29 O GLY A 16 SHEET 4 B 4 GLY A 119 GLY A 122 1 N GLY A 119 O VAL A 30 SHEET 1 C 4 TRP A 39 PRO A 41 0 SHEET 2 C 4 ILE A 94 MET A 107 1 N GLY A 102 O VAL A 40 SHEET 3 C 4 GLY A 78 VAL A 91 -1 N VAL A 91 O ILE A 94 SHEET 4 C 4 GLU A 70 TYR A 75 -1 N TYR A 75 O GLY A 78 SHEET 1 D 3 GLN A 191 MET A 194 0 SHEET 2 D 3 CYS A 210 VAL A 214 -1 N ALA A 212 O ILE A 192 SHEET 3 D 3 TRP A 299 LEU A 301 1 N TRP A 299 O LEU A 213 SHEET 1 E 3 VAL A 197 VAL A 199 0 SHEET 2 E 3 ILE A 258 LEU A 262 -1 N SER A 259 O SER A 198 SHEET 3 E 3 LYS A 265 LEU A 269 -1 N LEU A 269 O ILE A 258 SHEET 1 F 2 ILE A 221 GLY A 223 0 SHEET 2 F 2 ILE A 286 ALA A 288 1 N HIS A 287 O ILE A 221 SHEET 1 G 2 VAL A 246 LYS A 248 0 SHEET 2 G 2 LEU A 281 THR A 283 -1 N CYS A 282 O VAL A 247 SHEET 1 H 6 SER B 2 LEU B 6 0 SHEET 2 H 6 GLY B 163 LEU B 167 -1 N LEU B 167 O SER B 2 SHEET 3 H 6 VAL B 150 TYR B 155 -1 N TYR B 154 O GLN B 164 SHEET 4 H 6 PHE B 309 ASP B 314 -1 N PHE B 313 O PHE B 151 SHEET 5 H 6 ARG B 319 LEU B 324 -1 N ALA B 323 O TYR B 310 SHEET 6 H 6 HIS B 180 ASN B 183 -1 N ILE B 182 O ILE B 320 SHEET 1 I 2 THR B 7 TYR B 9 0 SHEET 2 I 2 GLN B 13 TYR B 15 -1 N TYR B 15 O THR B 7 SHEET 1 J 3 GLY B 16 ILE B 20 0 SHEET 2 J 3 GLN B 25 ASP B 32 -1 N VAL B 29 O GLY B 16 SHEET 3 J 3 GLY B 119 GLY B 122 1 N GLY B 119 O VAL B 30 SHEET 1 K 4 TRP B 39 PRO B 41 0 SHEET 2 K 4 ILE B 94 MET B 107 1 N GLY B 102 O VAL B 40 SHEET 3 K 4 THR B 79 VAL B 91 -1 N VAL B 91 O ILE B 94 SHEET 4 K 4 THR B 69 ARG B 74 -1 N LEU B 73 O VAL B 80 SHEET 1 L 3 GLN B 191 MET B 194 0 SHEET 2 L 3 CYS B 210 VAL B 214 -1 N ALA B 212 O ILE B 192 SHEET 3 L 3 TRP B 299 LEU B 301 1 N TRP B 299 O LEU B 213 SHEET 1 M 4 LYS B 265 LEU B 269 0 SHEET 2 M 4 ILE B 258 LEU B 262 -1 N LEU B 262 O LYS B 265 SHEET 3 M 4 VAL B 197 VAL B 199 -1 N SER B 198 O SER B 259 SHEET 4 M 4 SER B 202 LEU B 205 -1 N LEU B 205 O VAL B 197 SHEET 1 N 2 ILE B 221 GLY B 223 0 SHEET 2 N 2 ILE B 286 ALA B 288 1 N HIS B 287 O ILE B 221 SHEET 1 O 3 LYS B 238 ARG B 240 0 SHEET 2 O 3 ASP B 244 LYS B 248 -1 N VAL B 246 O LYS B 238 SHEET 3 O 3 LEU B 281 THR B 283 -1 N CYS B 282 O VAL B 247 SSBOND 1 CYS A 45 CYS A 50 1555 1555 1.98 SSBOND 2 CYS A 206 CYS A 210 1555 1555 2.01 SSBOND 3 CYS A 249 CYS A 282 1555 1555 2.00 SSBOND 4 CYS B 45 CYS B 50 1555 1555 2.03 SSBOND 5 CYS B 206 CYS B 210 1555 1555 1.99 SSBOND 6 CYS B 249 CYS B 282 1555 1555 2.04 CISPEP 1 THR A 22 PRO A 23 0 -2.33 CISPEP 2 LEU A 110 PRO A 111 0 11.07 CISPEP 3 PRO A 293 PRO A 294 0 4.87 CISPEP 4 GLY A 296 PRO A 297 0 -1.57 CISPEP 5 THR B 22 PRO B 23 0 -2.92 CISPEP 6 LEU B 110 PRO B 111 0 10.37 CISPEP 7 PRO B 293 PRO B 294 0 1.79 CISPEP 8 GLY B 296 PRO B 297 0 -6.62 SITE 1 AC1 18 ASP A 32 GLY A 34 TYR A 75 SER A 76 SITE 2 AC1 18 THR A 77 PRO A 111 PHE A 117 ASP A 215 SITE 3 AC1 18 GLY A 217 ALA A 218 SER A 219 TYR A 220 SITE 4 AC1 18 SER A 222 HIS A 287 MET A 289 ALA A 300 SITE 5 AC1 18 HOH A 803 HOH A 879 SITE 1 AC2 15 ASP B 32 GLY B 34 TYR B 75 SER B 76 SITE 2 AC2 15 THR B 77 PRO B 111 PHE B 117 ASP B 215 SITE 3 AC2 15 GLY B 217 ALA B 218 SER B 219 TYR B 220 SITE 4 AC2 15 SER B 222 ILE B 291 HOH B 887 CRYST1 143.100 143.100 143.100 90.00 90.00 90.00 P 21 3 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006988 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006988 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006988 0.00000